Cetera Investment Advisers grew its stake in shares of CME Group Inc (NASDAQ:CME) by 11.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,613 shares of the financial services provider’s stock after acquiring an additional 166 shares during the period. Cetera Investment Advisers’ holdings in CME Group were worth $312,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of CME. Advantage Investment Management LLC grew its stake in shares of CME Group by 119.0% during the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after buying an additional 100 shares during the period. Westside Investment Management Inc. purchased a new stake in shares of CME Group during the 2nd quarter valued at $38,000. Close Asset Management Ltd purchased a new stake in shares of CME Group during the 1st quarter valued at $34,000. Permanens Capital L.P. purchased a new stake in shares of CME Group during the 1st quarter valued at $41,000. Finally, Patriot Financial Group Insurance Agency LLC boosted its position in CME Group by 209.4% during the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 263 shares of the financial services provider’s stock worth $53,000 after purchasing an additional 178 shares during the period. Institutional investors own 84.99% of the company’s stock.
In other news, insider Sunil Cutinho sold 1,990 shares of the stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $202.38, for a total transaction of $402,736.20. Following the transaction, the insider now owns 31,182 shares in the company, valued at approximately $6,310,613.16. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Tuesday, July 9th. The stock was sold at an average price of $201.30, for a total transaction of $503,250.00. Following the transaction, the chief financial officer now owns 32,854 shares in the company, valued at approximately $6,613,510.20. The disclosure for this sale can be found here. Insiders have sold 59,626 shares of company stock valued at $12,255,934 over the last 90 days. 1.20% of the stock is currently owned by insiders.Shares of CME Group stock traded up $0.42 on Friday, hitting $205.80. The company had a trading volume of 974,804 shares, compared to its average volume of 1,132,937. The business has a 50-day simple moving average of $211.25 and a 200-day simple moving average of $191.16. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05. The company has a market cap of $72.54 billion, a PE ratio of 30.18, a PEG ratio of 4.51 and a beta of 0.19. CME Group Inc has a 52 week low of $161.05 and a 52 week high of $224.91.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The business’s revenue was up 20.1% on a year-over-year basis. During the same period last year, the firm posted $1.74 earnings per share. On average, equities research analysts predict that CME Group Inc will post 6.69 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date is Monday, September 9th. CME Group’s payout ratio is 43.99%.
CME has been the subject of a number of research reports. Wells Fargo & Co upped their price target on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Thursday. Deutsche Bank boosted their price objective on shares of CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a report on Friday, August 9th. Barclays boosted their price objective on shares of CME Group from $191.00 to $197.00 and gave the stock an “overweight” rating in a report on Thursday, May 23rd. Finally, Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective on the stock. in a report on Monday, May 27th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the stock. CME Group currently has an average rating of “Hold” and a consensus price target of $196.85.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Read More: How to trade the most active stocks
Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.